TrialBlood advances2018

Valproate in combination with rituximab and CHOP as first-line therapy in diffuse large B-cell lymphoma (VALFRID).

Kristina Drott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.